+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hospital Infection Therapeutics Market by Drug Class (Antibiotics, Antifungals, Antiseptics), Route Of Administration (Inhalation, Oral, Parenteral), End User, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Hospital Infection Therapeutics Market by Drug Class (Antibiotics, Antifungals, Antiseptics), Route Of Administration (Inhalation, Oral, Parenteral), End User, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Sale

Hospital Infection Therapeutics Market by Drug Class (Antibiotics, Antifungals, Antiseptics), Route Of Administration (Inhalation, Oral, Parenteral), End User, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905131
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hospital infection therapeutics market is entering a period of accelerating transformation as healthcare systems contend with rising pathogen resistance and evolving clinical demands. Senior leaders seeking actionable data and strategic clarity will find this report offers a comprehensive and targeted view of sector-specific challenges, solutions, and competitive dynamics.

Market Snapshot: Hospital Infection Therapeutics Market Growth and Outlook

The hospital infection therapeutics market grew from USD 6.38 billion in 2024 to USD 6.92 billion in 2025. It is expected to continue growing at a CAGR of 8.30%, reaching USD 10.30 billion by 2030. This expansion reflects heightened attention to multidrug-resistant organisms, shifts in care delivery models, and sustained investment in advanced pharmaceutical innovation. Sector momentum is fueled by investment in novel drug development, regulatory reforms, and greater urgency around patient safety initiatives across developed and emerging regions.

Scope & Segmentation

This report delivers in-depth segmentation and comprehensive insights to support data-driven planning:

  • Drug Classes: Antibiotics (carbapenems, cephalosporins, fluoroquinolones, macrolides, penicillins), Antifungals (azoles, echinocandins, polyenes), Antiseptics (alcohol based, chlorhexidine, iodophors), and Antivirals (anti-HBV, anti-HCV, anti-HIV, anti-influenza).
  • Routes of Administration: Inhalation, oral, parenteral (intramuscular, intravenous, subcutaneous), topical.
  • End Users: Ambulatory surgery centers, clinics, home healthcare providers, hospitals.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail outlets, wholesalers.
  • Applications: Palliative care, prophylaxis (pre-operative, post-operative), treatment protocols (empirical, targeted).
  • Regions Covered: Americas (with detailed analysis on countries and key US states), Europe, Middle East & Africa, Asia-Pacific—including major economies and emerging healthcare hubs.
  • Companies Featured: Pfizer Inc., Merck & Co., GlaxoSmithKline plc, Sanofi S.A., F. Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, AbbVie Inc., Astellas Pharma Inc., DAIICHI SANKYO COMPANY.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Escalating antimicrobial resistance is heightening scrutiny on existing hospital infection therapeutics, driving the need for personalized regimens and updated stewardship strategies.
  • Rapid diagnostics and digital monitoring platforms are enabling tailored interventions, directly impacting prescribing trends and resistance management.
  • Innovations in drug delivery, such as targeted agents and host-directed therapies, are shaping how healthcare providers mitigate hospital-acquired infection risks across varied patient populations.
  • Regulatory agility, including streamlined approvals and stewardship guidance updates, is fostering faster integration of next-generation therapies and diagnostics into care pathways.
  • Regional variations in infrastructure, access, and procurement—such as centralized European purchasing or Asia-Pacific manufacturing capabilities—impact therapeutic adoption and pricing models.
  • Strategic alliances and digital health integration are expanding the reach and clinical relevance of hospital infection therapeutics, offering new approaches for real-time resistance tracking and patient management.

Tariff Impact: Navigating Regulatory and Supply Chain Complexity

The introduction of United States tariffs in 2025 has significantly influenced the hospital infection therapeutics supply chain. Increased import duties on raw materials elevate production costs, prompting organizations to reconsider sourcing strategies and logistics. New regulatory measures and delayed shipments have driven a shift to domestically localized manufacturing and more robust buffer stock maintenance, emphasizing the critical need for procurement agility and risk mitigation. Contract negotiations increasingly include tariff mitigation terms to support uninterrupted therapeutic access and manage budgetary exposure.

Methodology & Data Sources

This report leverages primary insight from interviews with infectious disease specialists, pharmacists, and supply chain executives, integrated with secondary analysis of peer-reviewed literature, regulatory filings, and industry data. Analytical tools include SWOT, PESTEL, and value chain mapping. Data underwent rigorous validation through multiple sources and expert review, ensuring transparency and robustness throughout.

Why This Report Matters

  • Supports strategic planning by clarifying market dynamics, technology usage, and the evolving regulatory environment in hospital infection therapeutics.
  • Enables operational leaders to benchmark supply chain best practices and align with emerging diagnostic and therapeutic innovations.
  • Empowers commercial and procurement teams to assess segmentation trends, regional market specifics, and partnership opportunities within a single, actionable resource.

Conclusion

This executive summary distills the complex forces driving hospital infection therapeutics, delivering market intelligence to support informed decision-making. Stakeholders can navigate shifting clinical, regulatory, and trade landscapes with confidence by leveraging these comprehensive insights.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of hospital-based antimicrobial stewardship programs reducing resistance emergence by optimizing antibiotic usage
5.2. Adoption of rapid molecular diagnostics enabling targeted infection therapy within hours of patient admission
5.3. Increasing integration of AI-driven predictive analytics for early detection of hospital-acquired infections
5.4. Development of bacteriophage cocktails targeting multidrug-resistant Pseudomonas aeruginosa in critical care settings
5.5. Emergence of monoclonal antibody adjunctive therapies for prevention of Clostridioides difficile infection recurrence
5.6. Implementation of antimicrobial surface coatings on medical devices to prevent biofilm formation in catheters
5.7. Expansion of telehealth-based infectious disease consultation services to manage inpatient antimicrobial protocols
5.8. Regulatory initiatives mandating real-time antibiotic usage tracking and reporting across hospital networks
5.9. Advances in CRISPR-Cas antimicrobials designed to selectively eliminate drug-resistant bacterial strains in hospitals
5.10. Utilization of next-generation sequencing for real-time surveillance of resistance gene transmission pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hospital Infection Therapeutics Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Carbapenems
8.2.2. Cephalosporins
8.2.3. Fluoroquinolones
8.2.4. Macrolides
8.2.5. Penicillins
8.3. Antifungals
8.3.1. Azoles
8.3.2. Echinocandins
8.3.3. Polyenes
8.4. Antiseptics
8.4.1. Alcohol Based
8.4.2. Chlorhexidine
8.4.3. Iodophors
8.5. Antivirals
8.5.1. Anti-HBV
8.5.2. Anti-HCV
8.5.3. Anti-HIV
8.5.4. Anti-Influenza
9. Hospital Infection Therapeutics Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Oral
9.4. Parenteral
9.4.1. Intramuscular
9.4.2. Intravenous
9.4.3. Subcutaneous
9.5. Topical
10. Hospital Infection Therapeutics Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.4. Home Healthcare
10.5. Hospitals
11. Hospital Infection Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.5. Wholesalers
12. Hospital Infection Therapeutics Market, by Application
12.1. Introduction
12.2. Palliative
12.3. Prophylaxis
12.3.1. Post-Operative
12.3.2. Pre-Operative
12.4. Treatment
12.4.1. Empirical
12.4.2. Targeted Therapy
13. Americas Hospital Infection Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hospital Infection Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hospital Infection Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Merck & Co., Inc.
16.3.3. GlaxoSmithKline plc
16.3.4. Sanofi S.A.
16.3.5. F. Hoffmann-La Roche Ltd
16.3.6. Novartis AG
16.3.7. Bayer AG
16.3.8. AbbVie Inc.
16.3.9. Astellas Pharma Inc.
16.3.10. DAIICHI SANKYO COMPANY
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HOSPITAL INFECTION THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HOSPITAL INFECTION THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HOSPITAL INFECTION THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HOSPITAL INFECTION THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. HOSPITAL INFECTION THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. HOSPITAL INFECTION THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. HOSPITAL INFECTION THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HOSPITAL INFECTION THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ALCOHOL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ALCOHOL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CHLORHEXIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CHLORHEXIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY IODOPHORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY IODOPHORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HBV, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HBV, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HCV, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HCV, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PALLIATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PALLIATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PRE-OPERATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PRE-OPERATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY EMPIRICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY EMPIRICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 167. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 173. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 174. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 175. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 176. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 177. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 180. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 181. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 188. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 189. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 190. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 191. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 204. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 205. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 214. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Bayer AG
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • DAIICHI SANKYO COMPANY

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.3 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Infectious Disease Therapeutics Market by Drug Class (Antibiotics, Antifungals, Antivirals), Route Of Administration (Inhalation, Intravenous, Oral), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Infectious Disease Therapeutics Market by Drug Class (Antibiotics, Antifungals, Antivirals), Route Of Administration (Inhalation, Intravenous, Oral), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Hospital Infection Therapeutics Market 2025-2029 - Product Image

Hospital Infection Therapeutics Market 2025-2029

  • Report
  • 231 Pages
  • Global
From
Antifungal Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Antifungal Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Antifungal Treatment - Global Strategic Business Report - Product Image

Antifungal Treatment - Global Strategic Business Report

  • Report
  • 590 Pages
  • Global
From

About the Hospital Acquired Infection Drug Market

The Hospital Acquired Infection Drug market is a subset of the Infectious Diseases Drugs market. It focuses on drugs used to treat infections acquired in a hospital setting, such as Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff). These drugs are typically antibiotics, antivirals, antifungals, and antiparasitics. They are used to treat infections that are resistant to traditional treatments, or to prevent infections in patients with weakened immune systems. The Hospital Acquired Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.